(Q37229876)

English

Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike?

scientific article published on January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike? (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Carl J Lavie

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

author name string

Bijesh P Maroo

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Richard V Milani

3

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

649-664

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

https://scigraph.springernature.com/pub.10.2165/00002512-200825080-00003

0 references

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00003

21 January 2018

Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00003

21 January 2018

Current perspectives on statins

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00003

21 January 2018

Molecular basis of cardiovascular drug metabolism: implications for predicting clinically important drug interactions

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00003

21 January 2018

Statin-associated myopathy with normal creatine kinase levels

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00003

21 January 2018

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00003

21 January 2018

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanistic studies on metabolic interactions between gemfibrozil and statins

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of pravastatin in the elderly at risk: new hope for older persons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of combined pravastatin-gemfibrozil therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose statins in acute coronary syndromes: not just lipid levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health promotion and disease prevention in the elderly. Comparison of house staff and attending physician attitudes and practices.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An assessment of statin safety by nephrologists

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefits of Cardiac Rehabilitation and Exercise Training in Older Persons

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid lowering medication and hepatotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosuvastatin in older patients with systolic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statin wars: emphasis on potency vs event reduction and safety?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statin therapy in the elderly: observational and randomized controlled trials support event reduction.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Task force III: Major demographic and epidemiologic trends affecting adult cardiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes in 45 patients with statin-associated myopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein levels and outcomes after statin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The issue of statin safety: where do we stand?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statin safety: what to know.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol > 125 mg/dl

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerivastatin and reports of fatal rhabdomyolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rhabdomyolysis after taking atorvastatin with gemfibrozil

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment and treatment of lipids in elderly persons

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular risk factors in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The evolving role of statins in the management of atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid-lowering therapy for elderly patients at risk for coronary events and stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors: the role of metabolism-monograph for physicians

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and long-term adverse effect pattern of lovastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are we biased in our approach to treating elderly patients with heart disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and statin therapy: reconsidering the risks and benefits

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance and management of dyslipidemia in the metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002512-200825080-00003

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37229876&oldid=2161194984"